Document is current

Idarucizumab: A Review as a Reversal Agent for Dabigatran

Crossref DOI link: https://doi.org/10.1007/s40256-016-0181-4

Published Online: 2016-07-07

Published Print: 2016-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy